The forecasted data for new extrapulmonary tuberculosis cases in the US indicates a declining trend from 2024 (1.48 thousand cases) to 2028 (1.22 thousand cases). The year-on-year decrease ranges from approximately 4.7% in 2025 to 4.7% in 2028. This steady decrease suggests ongoing improvements in disease control and prevention efforts. The compound annual growth rate (CAGR) over this period suggests an average annual reduction in cases.
In terms of future trends, watch for:
- Advancements in medical technology and diagnostics potentially accelerating the decline in case numbers.
- Public health initiatives targeting high-risk populations and improving access to care influencing case rates.
